Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NATIONAL HEALTHCARE CORPNHC · Entity 355 | Senior VP & General Counsel | August 31, 2018 | September 05, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NATIONAL HEALTHCARE CORP
Report date August 31, 2018 · Filed September 05, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 24,453 |
Reported balance
After 2018-08-31 transaction · row 1
1 source rowRow 1 · 2018-08-31 · Sale · Disposed 9,350 · Balance 24,453 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $72.94 · Expires 2022-03-11 | Direct | 60,000 |
Reported balance
Holding disclosure · report date 2018-08-31 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 60,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2018 Filed Sep 5, 2018 20:45 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleCommon Stock | 9,350 | $77.30 | $722,755.00 |
DisclosureSEC source: 0001437749-18-016620 · rdgdoc.xml · nonDerivative · entry 1 LINES JOHN K · CIK 0001328762 · Senior VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,453 Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 19:48 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 60,000 | $0.00 Strike: $72.94 | $0.00 |
DisclosureSEC source: 0001047335-17-000072 · edgar.xml · derivative · entry 2 LINES JOHN K · CIK 0001328762 · Senior VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2022-03-11 F1 · shares: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive plan on March 14, 2017. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.